Janux Therapeutics JANX
NASDAQ JANX
$16.93 -0.03 (-0.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Interest & Investment Income (2021 - 2026)

Updated

Janux Therapeutics' Interest & Investment Income came in at $9.72 million for Q2 2026, down 13.7% from $11.26 million a year earlier and down 1.4% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Interest & Investment Income (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Janux Therapeutics reported Interest & Investment Income of $40.96 million, up 4.4% year-over-year; for FY2025, it was $44.04 million, up 47.5% from FY2024.

  • Interest & Investment Income has increased in each of the last three years, with a four-year compound annual growth rate of 261.8% (FY2021 to FY2025).
  • Going back by year, Interest & Investment Income was $29.85 million in FY2024 (+103.3%), $14.69 million in FY2023 (+264.2%), $4.03 million in FY2022 and $257,000 in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Interest & Investment Income since Q4 2024.
  • Year-over-year, Interest & Investment Income increased in six of the last eight quarters, with growth averaging 46.3%.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q3 2022 (growth of 867.9%), and the weakest in Q2 2026 (a decline of 13.7%).
  • Business Quant data shows JANX's Interest & Investment Income at $9.85 million (Q1 2026), $10.46 million (Q4 2025) and $10.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Janux Therapeutics 1.03 Bn 1.03 Bn - 9.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.72 Mn
Mar 31, 2026 9.85 Mn
Dec 31, 2025 10.46 Mn
Sep 30, 2025 10.94 Mn
Jun 30, 2025 11.26 Mn
Mar 31, 2025 11.39 Mn
Dec 31, 2024 8.81 Mn
Sep 30, 2024 7.78 Mn
Jun 30, 2024 7.86 Mn
Mar 31, 2024 5.40 Mn
Dec 31, 2023 4.38 Mn
Sep 30, 2023 4.25 Mn
Jun 30, 2023 3.24 Mn
Mar 31, 2023 2.82 Mn
Dec 31, 2022 2.20 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 373,000.00
Mar 31, 2022 132,000.00
Dec 31, 2021 74,000.00
Sep 30, 2021 137,000.00
API Access

Janux Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=JANX&period=max&api_key=YOUR_API_KEY